A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty

British Journal of Haematology

Volumn 129, Issue 1, 2005, Pages 87-92

  Joseph, Joanne E ^a,b   Low, Joyce ^a   Courtenay, Brett ^a   Neil, Michael J ^a   McGrath, Michael ^a   Ma, David ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Arthroplasty; Clinical risk factors; Thrombophilia; Venous thromboembolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGE; AGED; ARTICLE; BANDAGE; BLOOD SAMPLING; BLOOD TRANSFUSION; ELECTIVE SURGERY; FEMALE; GENE MUTATION; GENERAL ANESTHESIA; GENOTYPE; HEMOSTASIS; HIP ARTHROPLASTY; HUMAN; HYPERCOAGULABILITY; INCIDENCE; KNEE ARTHROPLASTY; LUNG PERFUSION; LUNG SCINTISCANNING; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCREENING; SURGICAL DRAINAGE; SYMPTOMATOLOGY; TECHNIQUE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; EPIDEMIOLOGIC METHODS; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATIONS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 17144418105     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05419.x     Document Type: Article

References (22)

1. Anders, M.J., Lifeso, R.M., Landis, M., Mikulsky, J., Meinking, C. & McCracken, K.S. (1996) Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee. The Journal of Bone and Joint Surgery (American), 78, 574-580.
2. Bauer, K.A., Eriksson, B.I., Lassen, M.R. & Turpie, A.G. (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. The New England Journal of Medicine, 345, 1305-1310.
3. Bottner, F. & Sculco, T.P. (2001) Nonpharmacologic thromboembolic prophylaxis in total knee arthroplasty. Clinical Orthopaedics and Related Research, 392, 249-256.
4. Cohen, A.T., Bailey, C.S., Alikhan, R. & Cooper, D.J. (2001) Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty - a meta-analysis. Thrombosis and Haemostasis, 85, 940-941.
5. Colwell, C.W., Jr, Berkowitz S.D., Davidson, B.L., Lotke, P.A., Ginsberg, J.S., Lieberman, J.R., Neubauer, J., McElhattan, J.L., Peters, G.R. & Francis, C.W. (2003) Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study. Journal of Thrombosis and Haemostasis, 1, 2119-2130.
6. Eikelboom, J.W., Quinlan, D.J. & Douketis, J.D. (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet, 358, 9-15.
7. Eriksson, B.I., Agnelli, G., Cohen, A.T., Dahl, O.E., Lassen, M.R., Mouret, P., Rosencher, N., Kalebo, P., Panfilov, S., Eskilson, C., Andersson, M. & Freij, A.; Express Study Group (2003) The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: The Express Study. Journal of Thrombosis and Haemostasis, 1, 2490-2496.
8. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J., den Heijer, M., Kluijtmans, L.A., van den Heuvel, L.P. & Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111-113.
9. Geerts, W.H., Heit, J.A., Clagett, G.P., Pineo, G.F., Colwell, C.W., Anderson, Jr, F.A. & Wheeler, H.B. (2001) Prevention of venous thromboembolism. Chest, 119, 132S-175S.
10. Haas, S.B., Tribus, C.B., Insall, J.N., Becker, M.W. & Windsor, R.E. (1992) The significance of calf thrombi after total knee arthroplasty. Journal of Bone and Joint Surgery (British), 74-B, 799-802.
11. Hull, R.D., Pineo, G.F., Stein, P.D., Mah, A.F., MacIsaac, S.M., Dahl, O.E., Butcher, M., Brant, R.F., Ghali, W.A., Bergqvist, D. & Raskob, G.E. (2001) Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Annals of Internal Medicine, 135, 858-869.
12. Leizorovicz, A., Kassai, B., Becker, F. & Cucherat, M. (2003) The assessment of deep vein thromboses for therapeutic trials. Angiology, 54, 19-24.
13. Lindahl, T.L., Lundahl, T.H., Nilsson, L. & Andersson, C.A. (1999) APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee-a prospective study. Thrombosis and Haemostasis, 81, 18-21.
14. Lowe, G.D., Haverkate, F., Thompson, S.G., Turner, R.M., Bertina, R.M., Turpie, A.G. & Mannucci, P.M. (1999) Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European concerted action on thrombosis. Thrombosis and Haemostasis, 81, 879-886.
15. Mantilla, C.B., Horlocker, T.T., Schroeder, D.R., Berry, D.J. & Brown, D.L. (2003) Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology, 99, 552-560.
16. Philipp, C.S., Dilley, A., Saidi, P., Evatt, B., Austin, H., Zawadsky, J., Harwood, D., Ellingsen, D Barnhart, E., Phillips, D.J. & Hooper, W.C. (1998) Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thrombosis and Haemostasis, 80, 869-873.
17. Ripoll, L., Paulin, D., Thomas, S. & Drouet, L. (1997) Multiplex PCR-mediated site-directed mutagenesis for one-step determination of Factor V Leiden and G20210A transition of the prothrombin gene. Thrombosis and Haemostasis, 78, 960-961.
18. Ryan, D.H., Crowther, M.A., Ginsberg, J.S. & Francis, C.W. (1998) Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Annals of Internal Medicine, 15, 270-276.
19. Tay, J.C. & McGrath, M. (1999) Ultrasound surveillance for deep venous thrombosis in postoperative patients. 2nd Asia Pacific Interscience Congress of Medicine, Singapore (abstract).
20. Turpie, A.G., Callus, A.S. & Hoek, J.A. (2001) A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. New England Journal of Medicine, 344, 619-625.
21. Vaitkus, P.T., Leizorovicz, A., Cohen, A.T., Turpie, A.G.G., Olsson, C.-G & Goldhaber, S.Z. for the PREVENT Medical Thromboprophylaxis Study Group (2005). Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thrombosis and Haemostasis, 93, 76-79.
22. Wahlander, K., Larson, G., Lindahl, T.L., Andersson, C., Frison, L., Gustafsson, D., Bylock, A. & Eriksson, B.I. (2002) Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thrombosis and Haemostasis, 87, 580-585